XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated statements of changes in equity
USD ($)
shares
Stock options
USD ($)
Restricted share units
USD ($)
Series C Shares
USD ($)
Public Shares
USD ($)
Share capital
USD ($)
shares
Share capital
Restricted share units
USD ($)
shares
Share capital
Series C Shares
USD ($)
shares
Share capital
Public Shares
USD ($)
shares
Contributed surplus
USD ($)
Contributed surplus
Stock options
USD ($)
Contributed surplus
Restricted share units
USD ($)
Accumulated deficit
USD ($)
Accumulated other comprehensive income (loss)
USD ($)
Equity attributable to the Shareholders of Li-Cycle Holdings Corp.
USD ($)
Equity attributable to the Shareholders of Li-Cycle Holdings Corp.
Stock options
USD ($)
Equity attributable to the Shareholders of Li-Cycle Holdings Corp.
Restricted share units
USD ($)
Non-controlling interest
USD ($)
Shareholders' equity, beginning balance (in shares) at Oct. 31, 2020 | shares           83,361,291                        
Shareholders' equity, beginning balance at Oct. 31, 2020 $ 1,440,730         $ 15,441,600       $ 824,683     $ (14,528,941) $ (296,612) $ 1,440,730      
Changes in equity [abstract]                                    
Stock option expense   $ 404,443 $ 0               $ 404,443 $ 0       $ 404,443    
Share issuance (in shares) | shares               11,220,218 0                  
Share issuance       $ 21,620,000 $ 0     $ 21,620,000 $ 0           21,620,000      
Shares issued for non-cash costs (in shares) | shares           478,920                        
Equity issued for non-cash costs 0         $ 455,055       (455,055)                
Exercise of stock options (in shares) | shares           0                        
Exercise of stock options 0         $ 0       0                
Exercise of warrants (in shares) | shares           0                        
Exercise of warrants 0         $ 0       0                
Restricted Share Units settled in shares (in shares) | shares             0                      
Restricted Share Units settled in shares     0       $ 0                      
Comprehensive loss (14,693,465)                       (14,693,465)   (14,693,465)      
Shareholders' equity, ending balance (in shares) at Apr. 30, 2021 | shares           95,060,429                        
Shareholders' equity, ending balance at Apr. 30, 2021 8,771,708         $ 37,516,655       774,071     (29,222,406) (296,612) 8,771,708      
Shareholders' equity, beginning balance (in shares) at Oct. 31, 2021 | shares           163,179,655                        
Shareholders' equity, beginning balance at Oct. 31, 2021 433,721,034         $ 672,079,154       3,026,721     (241,088,229) (296,612) 433,721,034     $ 0
Changes in equity [abstract]                                    
Stock option expense 4,136,896                 4,136,896         4,136,896      
Share issuance (in shares) | shares           0                        
Share issuance $ 0                                
Exercise of stock options (in shares) | shares 222,505         188,745                        
Exercise of stock options $ 0         $ 177,918       (177,918)                
Exercise of warrants (in shares) | shares           5,712,222                        
Exercise of warrants 46,001,223         $ 46,001,223       0         46,001,223      
Restricted Share Units settled in shares (in shares) | shares             0                      
Restricted Share Units settled in shares     $ 5,539,268       $ 0         $ 5,539,268         $ 5,539,268  
Non-controlling interest in subsidiary 330,000                                 330,000
Comprehensive loss 7,896,265                       7,919,939 0 7,919,939     (23,674)
Shareholders' equity, ending balance (in shares) at Apr. 30, 2022 | shares           169,080,622                        
Shareholders' equity, ending balance at Apr. 30, 2022 $ 497,624,686         $ 718,258,295       $ 12,524,967     $ (233,168,290) $ (296,612) $ 497,318,360     $ 306,326